| Product Code: ETC12465582 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Immunotherapy Drugs Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Immunotherapy Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Ireland Immunotherapy Drugs Market - Industry Life Cycle |
3.4 Ireland Immunotherapy Drugs Market - Porter's Five Forces |
3.5 Ireland Immunotherapy Drugs Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.6 Ireland Immunotherapy Drugs Market Revenues & Volume Share, By Cancer Type, 2021 & 2031F |
3.7 Ireland Immunotherapy Drugs Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Ireland Immunotherapy Drugs Market Revenues & Volume Share, By Mechanism of Action, 2021 & 2031F |
3.9 Ireland Immunotherapy Drugs Market Revenues & Volume Share, By Sales Channel, 2021 & 2031F |
4 Ireland Immunotherapy Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Ireland |
4.2.2 Growing adoption of immunotherapy as a preferred treatment option |
4.2.3 Favorable government initiatives and policies supporting immunotherapy research and development |
4.3 Market Restraints |
4.3.1 High cost associated with immunotherapy drugs |
4.3.2 Limited awareness and access to immunotherapy treatments in some regions of Ireland |
5 Ireland Immunotherapy Drugs Market Trends |
6 Ireland Immunotherapy Drugs Market, By Types |
6.1 Ireland Immunotherapy Drugs Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 Ireland Immunotherapy Drugs Market Revenues & Volume, By Drug Type, 2021 - 2031F |
6.1.3 Ireland Immunotherapy Drugs Market Revenues & Volume, By Checkpoint Inhibitors, 2021 - 2031F |
6.1.4 Ireland Immunotherapy Drugs Market Revenues & Volume, By Monoclonal Antibodies, 2021 - 2031F |
6.1.5 Ireland Immunotherapy Drugs Market Revenues & Volume, By Cancer Vaccines, 2021 - 2031F |
6.1.6 Ireland Immunotherapy Drugs Market Revenues & Volume, By Cytokines, 2021 - 2031F |
6.1.7 Ireland Immunotherapy Drugs Market Revenues & Volume, By Adoptive T-Cell Therapy, 2021 - 2031F |
6.2 Ireland Immunotherapy Drugs Market, By Cancer Type |
6.2.1 Overview and Analysis |
6.2.2 Ireland Immunotherapy Drugs Market Revenues & Volume, By Lung Cancer, 2021 - 2031F |
6.2.3 Ireland Immunotherapy Drugs Market Revenues & Volume, By Breast Cancer, 2021 - 2031F |
6.2.4 Ireland Immunotherapy Drugs Market Revenues & Volume, By Melanoma, 2021 - 2031F |
6.2.5 Ireland Immunotherapy Drugs Market Revenues & Volume, By Leukemia, 2021 - 2031F |
6.2.6 Ireland Immunotherapy Drugs Market Revenues & Volume, By Multiple Myeloma, 2021 - 2031F |
6.3 Ireland Immunotherapy Drugs Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Ireland Immunotherapy Drugs Market Revenues & Volume, By Oncology Centers, 2021 - 2031F |
6.3.3 Ireland Immunotherapy Drugs Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.4 Ireland Immunotherapy Drugs Market Revenues & Volume, By Specialty Clinics, 2021 - 2031F |
6.3.5 Ireland Immunotherapy Drugs Market Revenues & Volume, By Research Institutions, 2021 - 2031F |
6.3.6 Ireland Immunotherapy Drugs Market Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031F |
6.4 Ireland Immunotherapy Drugs Market, By Mechanism of Action |
6.4.1 Overview and Analysis |
6.4.2 Ireland Immunotherapy Drugs Market Revenues & Volume, By PD-1/PD-L1 Blocking, 2021 - 2031F |
6.4.3 Ireland Immunotherapy Drugs Market Revenues & Volume, By Immune System Activation, 2021 - 2031F |
6.4.4 Ireland Immunotherapy Drugs Market Revenues & Volume, By Tumor Cell Recognition, 2021 - 2031F |
6.4.5 Ireland Immunotherapy Drugs Market Revenues & Volume, By Signal Pathway Modulation, 2021 - 2031F |
6.4.6 Ireland Immunotherapy Drugs Market Revenues & Volume, By CAR-T Cell Therapy, 2021 - 2031F |
6.5 Ireland Immunotherapy Drugs Market, By Sales Channel |
6.5.1 Overview and Analysis |
6.5.2 Ireland Immunotherapy Drugs Market Revenues & Volume, By Direct Sales, 2021 - 2031F |
6.5.3 Ireland Immunotherapy Drugs Market Revenues & Volume, By Online Pharmacies, 2021 - 2031F |
6.5.4 Ireland Immunotherapy Drugs Market Revenues & Volume, By Wholesale Suppliers, 2021 - 2031F |
6.5.5 Ireland Immunotherapy Drugs Market Revenues & Volume, By Government Procurement, 2021 - 2031F |
6.5.6 Ireland Immunotherapy Drugs Market Revenues & Volume, By Hospital Contracts, 2021 - 2031F |
7 Ireland Immunotherapy Drugs Market Import-Export Trade Statistics |
7.1 Ireland Immunotherapy Drugs Market Export to Major Countries |
7.2 Ireland Immunotherapy Drugs Market Imports from Major Countries |
8 Ireland Immunotherapy Drugs Market Key Performance Indicators |
8.1 Number of clinical trials for immunotherapy drugs in Ireland |
8.2 Percentage increase in healthcare professionals trained in immunotherapy |
8.3 Patient satisfaction rates with immunotherapy treatments |
8.4 Number of partnerships between research institutions and pharmaceutical companies in the field of immunotherapy |
8.5 Percentage increase in overall survival rates of cancer patients undergoing immunotherapy treatments |
9 Ireland Immunotherapy Drugs Market - Opportunity Assessment |
9.1 Ireland Immunotherapy Drugs Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.2 Ireland Immunotherapy Drugs Market Opportunity Assessment, By Cancer Type, 2021 & 2031F |
9.3 Ireland Immunotherapy Drugs Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Ireland Immunotherapy Drugs Market Opportunity Assessment, By Mechanism of Action, 2021 & 2031F |
9.5 Ireland Immunotherapy Drugs Market Opportunity Assessment, By Sales Channel, 2021 & 2031F |
10 Ireland Immunotherapy Drugs Market - Competitive Landscape |
10.1 Ireland Immunotherapy Drugs Market Revenue Share, By Companies, 2024 |
10.2 Ireland Immunotherapy Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here